Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.93% is 27% below its 5-year average of 5.41%, near the low end of its 5-year range (3.93%–6.26%).
19.63% below its 12-month average of 4.89%.
Annual fiscal-year return on assets; no daily interpolation. Historical series through 2025-12-31.
RETURN ON ASSETS (ROA)
3.93%
RETURN ON ASSETS (ROA) AVG TTM
4.89%
RETURN ON ASSETS (ROA) AVG 3Y
5.25%
RETURN ON ASSETS (ROA) AVG 5Y
5.41%
RETURN ON ASSETS (ROA) AVG 10Y
5.18%
RETURN ON ASSETS (ROA) AVG 15Y
5.03%
RETURN ON ASSETS (ROA) AVG 20Y
5.14%
CURRENT VS TTM AVG
-19.63%
CURRENT VS 3Y AVG
-25.21%
CURRENT VS 5Y AVG
-27.36%
CURRENT VS 10Y AVG
-24.06%
CURRENT VS 15Y AVG
-21.80%
CURRENT VS 20Y AVG
-23.51%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-23.54%
vs the sector median at left
Elevance Health Inc.
Market Cap
$86.50B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$83.11B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
Market Cap
$91.81B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$72.86B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$104.80B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$67.48B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
Market Cap
$106.26B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | $86.50B | 3.93% | 4.89% | 5.25% | 5.41% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $83.11B | 10.37% | 11.40% | 12.40% | 16.97% |
| HCA Healthcare, Inc. (HCA)vs › | $91.81B | 11.30% | 10.43% | 10.23% | 10.42% |
| GSK plc (GSK)vs › | $97.77B | 7.91% | 6.85% | 11.28% | 9.07% |
| Cigna Corporation (CI)vs › | $72.86B | 4.08% | 2.99% | 3.50% | 3.82% |
| Sanofi (SNY)vs › | $103.21B | 3.12% | 5.18% | 5.31% | 6.19% |
| McKesson Corporation (MCK)vs › | $104.80B | 5.20% | 5.08% | 5.08% | 2.52% |
| Boston Scientific Corporation (BSX)vs › | $67.48B | 8.11% | 5.66% | 4.50% | 3.49% |
| Stryker Corporation (SYK)vs › | $106.26B | 7.78% | 6.88% | 7.02% | 6.41% |
| Cencora, Inc. (COR)vs › | $63.28B | 3.13% | 2.14% | 2.52% | 0.85% |
ROA
3.9%
ROE
11.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.66% |
| 2024-12-31 | 5.12% |
| 2023-12-31 | 5.50% |
| 2022-12-31 | 5.74% |
| 2021-12-31 | 6.26% |
| 2020-12-31 | 5.18% |
| 2019-12-31 | 6.14% |
| 2018-12-31 | 5.17% |
| 2017-12-31 | 5.38% |
| 2016-12-31 | 3.72% |
| 2015-12-31 | 4.06% |
| 2014-12-31 | 4.08% |
| 2013-12-31 | 4.39% |
| 2012-12-31 | 4.41% |
| 2011-12-31 | 4.97% |
| 2010-12-31 | 5.63% |
| 2009-12-31 | 9.10% |
| 2008-12-31 | 5.15% |
| 2007-12-31 | 6.43% |
| 2006-12-31 | 5.98% |
| 2005-12-31 | 4.79% |
| 2004-12-31 | 2.36% |
| 2003-12-31 | 5.77% |
| 2002-12-31 | 4.41% |
| 2001-12-31 | 5.40% |
| 2000-12-31 | 3.96% |
| 1999-12-31 | 0.93% |
| 1998-12-31 | 3.95% |
